Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home E-Commerce

Amazon’s Market Value Plummets in Tech Sector Rout

Felix Baarz by Felix Baarz
November 15, 2025
in E-Commerce, Market Commentary, Nasdaq, Tech & Software
0
Amazon Stock
0
SHARES
93
VIEWS
Share on FacebookShare on Twitter

Friday’s trading session delivered a severe blow to Amazon, as the e-commerce and cloud computing leader saw approximately $90 billion evaporate from its market capitalization. The dramatic single-day decline formed part of a broader technology sector sell-off that erased nearly $500 billion in combined value from industry giants including Meta, Nvidia, and Microsoft. Market participants are now questioning whether this represents a temporary setback or the beginning of a more sustained downturn.

Federal Reserve Policy Shift Rattles Markets

The primary catalyst for the technology sector’s decline emerged from comments by Federal Reserve Chairman Jerome Powell, who indicated that the central bank would maintain its current interest rate policy rather than implementing anticipated cuts. This hawkish stance delivered a sharp blow to equity markets, with technology stocks experiencing particular vulnerability to rising borrowing costs.

The yield on 10-year U.S. Treasury notes briefly surged to 4.5% before settling at 4.44%, creating challenging conditions for growth-oriented enterprises like Amazon. Higher interest rates typically translate to increased capital costs and compressed valuations for technology firms. Market expectations for December rate reductions have now been largely abandoned.

Nasdaq Suffers Significant Declines

The technology-heavy Nasdaq Composite index fell 2.2% during the session, while the Nasdaq 100 recorded its first five-day losing streak since January. Technology stocks registered as the worst-performing sector within the S&P 500, declining 2.5% collectively.

Amazon shares dropped 4% to close at $202.61, marking a substantial reversal from post-election optimism. Key trading metrics from the session revealed:

• Price range: $199.62 to $207.30 (representing 3.85% intraday volatility)
• Trading volume: 82 million shares valued at approximately $16.56 billion
• Market capitalization decline: exceeding $90 billion

Should investors sell immediately? Or is it worth buying Amazon?

Other major technology companies experienced similar pressure, with Meta and Nvidia declining 4% and 3% respectively, while Microsoft fell 3% and Alphabet dropped 2%.

Post-Election Optimism Fades as Concerns Mount

The market rally that followed Donald Trump’s election victory had propelled major indices to record levels, with Amazon benefiting from expectations of tax reductions and regulatory easing. However, market sentiment has deteriorated significantly in recent sessions.

Bank of America strategists have raised concerns about current market positioning, describing it as “dangerously bullish” while noting that technical indicators suggest further corrective action may be forthcoming. The prevailing question among analysts is no longer whether a correction will occur, but rather how severe it might become.

AWS Performance Provides Silver Lining

Despite the widespread market decline, Amazon’s cloud computing division AWS demonstrated remarkable resilience, achieving 20% growth—its strongest performance since 2022. This segment contributes approximately 60% of operating profits while generating only 15% of total revenue.

The robust AWS performance indicates that corporate investment in cloud services and artificial intelligence infrastructure remains strong. From a fundamental perspective, Amazon maintains a solid operational foundation, with current stock weakness primarily attributable to macroeconomic uncertainty rather than company-specific challenges. Whether this fundamental strength will provide sufficient support in the coming weeks remains uncertain as market nervousness persists.

Ad

Amazon Stock: Buy or Sell?! New Amazon Analysis from February 7 delivers the answer:

The latest Amazon figures speak for themselves: Urgent action needed for Amazon investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Amazon: Buy or sell? Read more here...

Tags: Amazon
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Conduent Stock
Cyber Security

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

February 7, 2026
Next Post
Fiserv Stock

Fiserv Shares Plunge Amid Deepening Crisis

Voestalpine Stock

Voestalpine's Strategic Shift Delivers Impressive Results

Microsoft Stock

Microsoft's Strategic AI Expansion Targets Global Data Sovereignty

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com